Silence Therapeutics appoints CFO Rhonda Hellums to Board of Directors effective Dec 18, 2025

Silence Therapeutics plc

Rhonda Hellums, EVP and CFO, appointed as executive director effective December 18, 2025.
Her initial term runs until the 2026 Annual General Meeting of Shareholders.
Ms. Hellums will not receive additional compensation for board service.
She will not serve on any board committee.
No family relationships or material transactions requiring disclosure.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.